Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6DXP
|
||||
Drug Name |
(S)-N-((S)-1-cyano-2-phenylethyl)-2-cyclopropyl-2-((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)biphenyl-4-yl)ethylamino)acetamide
|
||||
Synonyms |
CHEMBL1290303
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H28F3N3O3S
|
||||
Canonical SMILES |
CS(=O)(=O)c1ccc(cc1)c2ccc(cc2)[C@H](N[C@@H](C3CC3)C(=O)N[C@@H](Cc4ccccc4)C#N)C(F)(F)F
|
||||
InChI |
InChI=1S/C29H28F3N3O3S/c1-39(37,38)25-15-13-21(14-16-25)20-7-11-23(12-8-20)27(29(30,31)32)35-26(22-9-10-22)28(36)34-24(18-33)17-19-5-3-2-4-6-19/h2-8,11-16,22,24,26-27,35H,9-10,17H2,1H3,(H,34,36)/t24-,26-,27-/m0/s1
|
||||
InChIKey |
JLZPHDGPTVJCOI-URORMMCBSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.